PYXS Pyxis Oncology Inc
Company Analysis
Latest News
🟢 PYXS is trading 5.3% up today as investors look past discounted financing
PYXS is trading at 5.3% up now at $3.00 as the stock stabilizes after a sharp drop tied to its $114 million private placement priced below market. Investors...
🔴 PYXS is trading 5.2% down today after announcing a $114M private placement priced below market
PYXS is trading at $2.85 (-5.15%) after announcing a $114 million private placement financing priced at $2.551 per share, representing a discount to its prior...
🔴 PYXS is trading 7.6% down today after announcing a $114M private placement priced below market
PYXS is trading at $2.78 (7.6% down) after announcing a $114 million private placement financing priced significantly below its previous close. • The capital...
🟢 PYXS makes sharp 11.9% jump
PYXS is trading at $3.20, up 11.9% versus the comparison close of $2.86 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 PYXS is trading 10.1% up today after announcing a $50 million private placement commitment
PYXS is trading 10.1% up at $3.15 after Pyxis Oncology announced a commitment to approximately $50 million in private placement proceeds. • The stock carried...
🔴 PYXS makes sharp 11.5% drop
PYXS is trading at $2.53, down 11.5% versus the comparison close of $2.86 during pre-market. This is a price-movement alert; no separate company-specific...
🔴 PYXS is trading 8.4% down today despite announcing up to $114M private placement financing
PYXS is trading at $2.62 (8.4% down) today, following the company's announcement of a private placement expected to generate up to $114 million. - Pyxis...
Pyxis Oncology Surges 57% in a Week on Index Buying and Cancer Drug Hopes — But Can a Cash-Strapped Biotech Sustain the Momentum?
Shares of Pyxis Oncology rocketed to $3.30 in pre-market trading, extending a blistering 57% rally from $2.10 just five sessions ago, as the tiny cancer-drug...
🟢 PYXS surges 15.4% today on $114M private placement and Russell Microcap Growth Index inclusion
PYXS is trading at $3.30 (15.4%) in pre-market following an announcement of an up to $114 million private placement financing. • The financing, led by BVF...
🟢 PYXS is trading 5.4% up today following Russell Microcap Growth Index inclusion, ahead of Phase 1 MICVO data and financing decisions
PYXS is trading at $2.92 (up 5.4%), extending a sharp rally that began with a 24% jump to $2.77 on June 26, 2026. • Pyxis Oncology was added to the Russell...
Pyxis Oncology Awaits Critical MICVO Data as Cash Runway Nears End
Pyxis Oncology expects updated Phase 1 monotherapy data for its lead antibody-drug conjugate, MICVO, in mid-2026. The company’s stock surged 24% on June 26,...
🔴 PYXS is trading 6.5% down today on profit-taking after yesterday's 24% surge
PYXS is trading at $2.59, down 6.5%, as the stock undergoes a correction following a sharp 24.22% rally in the previous regular session. • The decline appears...
🟢 PYXS makes sharp 13.7% jump
PYXS is trading at $2.54, up 13.7% versus the comparison close of $2.23 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 PYXS is trading 9% up today on continued short-term momentum
PYXS is trading at $2.43 (up 9%) on continued short-term momentum, extending the stock's recent rebound despite a lack of fresh company-specific catalysts. •...
🟢 PYXS is trading 7.4% up today, extending its multi-day rebound
PYXS is trading 7.4% up today at $2.25, extending its strong multi-day rebound from the mid-$1 range. • The move appears to be momentum-driven following...
🟢 Pyxis Oncology Inc is trading 5.9% up today, extending a multi-day rally following upbeat Q1 results
Pyxis Oncology Inc is trading at $2.15 (5.9% up) today, extending a strong multi-day move following upbeat Q1 2026 results and clinical progress commentary...
🔴 Pyxis Oncology Inc is trading 6.9% down today on profit-taking after a recent rally
Pyxis Oncology Inc is trading at $1.89 (6.9% down) in pre-market, pulling back after a strong multi-day rally last week. • The move appears to reflect typical...
🟢 Pyxis Oncology Inc is trading 8.2% up today, extending a multi-day rebound on speculative buying
Pyxis Oncology Inc is trading 8.2% up at $2.06 today, extending a multi-day rebound from last week’s levels on relatively light, news-thin action. • The move...